Evidence map›Paper›PMID 34981352›Full record

Trial reportJournal of general internal medicine2022

Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD): an Implementation Trial in Eight Veterans Health Administration Facilities.

Hildi J Hagedorn, Allison M Gustavson, Princess E Ackland, Ann Bangerter, Mark Bounthavong, Barbara Clothier, Alex H S Harris, Marie E Kenny, Siamak Noorbaloochi, Hope A Salameh and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of general internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hildi J HagedornCenter for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, 1 Veterans Drive, Mil Code #152, Minneapolis, MN, 55417, USA. hildi.hagedorn@va.gov.
Allison M GustavsonCenter for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, 1 Veterans Drive, Mil Code #152, Minneapolis, MN, 55417, USA.
Princess E AcklandCenter for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, 1 Veterans Drive, Mil Code #152, Minneapolis, MN, 55417, USA.
Ann BangerterCenter for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, 1 Veterans Drive, Mil Code #152, Minneapolis, MN, 55417, USA.
Mark BounthavongHealth Economics Resource Center, Palo Alto Veterans Affairs Health Care System, Palo Alto, CA, 94025, USA.
Barbara ClothierCenter for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, 1 Veterans Drive, Mil Code #152, Minneapolis, MN, 55417, USA.
Alex H S HarrisCenter for Innovation To Implementation, Palo Alto Veterans Affairs Health Care System, Palo Alto, CA, 94025, USA.
Marie E KennyCenter for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, 1 Veterans Drive, Mil Code #152, Minneapolis, MN, 55417, USA.
Siamak NoorbaloochiCenter for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, 1 Veterans Drive, Mil Code #152, Minneapolis, MN, 55417, USA.
Hope A SalamehCenter for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, 1 Veterans Drive, Mil Code #152, Minneapolis, MN, 55417, USA.
Adam J GordonVulnerable Veteran Innovative PACT (VIP) Initiative; Informatics, Decision-Enhancement, and Analytic Sciences Center (IDEAS, Salt Lake City Veterans Affairs Health Care System, 500 Foothill Drive, Salt Lake City, UT, 84148, USA.

Funding

HSRD VA I01 HX002156
6 · The paper itself

Abstract

backgroundIdentifying effective strategies to improve access to medication treatments for opioid use disorder (MOUD) is imperative. Within the Veterans Health Administration (VHA), provision of MOUD varies significantly, requiring development and testing of implementation strategies that target facilities with low provision of MOUD.

objectiveDetermine the effectiveness of external facilitation in increasing the provision of MOUD among VHA facilities with low baseline provision of MOUD compared to matched controls.

designPre-post, block randomized study designed to compare facility-level outcomes in a stratified sample of eligible facilities. Four blocks (two intervention facilities in each) were defined by median splits of both the ratio of patients with OUD receiving MOUD and number of patients with OUD not currently receiving MOUD (i.e., number of actionable patients). Intervention facilities participated in a 12-month implementation intervention.

participantsVHA facilities in the lowest quartile of MOUD provision (35 facilities), eight of which were randomly assigned to participate in the intervention (two per block) with twenty-seven serving as matched controls by block.

interventionExternal facilitation included assessment of local barriers/facilitators, formation of a local implementation team, a site visit for action planning and training/education, cross-facility quarterly calls, monthly coaching calls, and consultation. MAIN MEASURES: Pre- to post-change in the facility-level ratio of patients with an OUD diagnosis receiving MOUD compared to control facilities. KEY

resultsIntervention facilities significantly increased the ratio of patients with OUD receiving MOUD from an average of 18% at baseline to 30% 1 year later, with an absolute difference of 12% (95% confidence interval [CI]: 6.6%, 17.0%). The difference in differences between intervention and control facilities was 3.0% (95% CI: - 0.2%. 6.7%). The impact of the intervention varied by block, with smaller, less complex facilities more likely to outperform matched controls.

conclusionsIntensive external facilitation improved the adoption of MOUD in most low-performing facilities and may enhance adoption beyond other interventions less tailored to individual facility contexts.

Indexed as

BuprenorphineOpioid-Related DisordersHumansOpiate Substitution TreatmentVeterans HealthBuprenorphineAdoptionEvidence-based practiceExternal facilitationImplementation scienceMedication treatment for opioid use disorderSubstance use disorder

Identifiers

PMID34981352
PMCPMC8722660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.